Risk of solid subsequent malignant neoplasms after childhood Hodgkin lymphoma–identification of high‐risk populations to guide surveillance: A report from the Late Effects Study Group

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

Abstract

<p class="first" id="d9942923e358">Survivors of Hodgkin lymphoma (HL) in childhood have an increased risk of subsequent malignant neoplasms (SMNs). Herein, the authors extended the follow-up of a previously reported Late Effects Study Group cohort and identified patients at highest risk for SMNs to create evidence for risk-based screening recommendations. </p>

Related collections

Author and article information

Journal

Title: Cancer

Abbreviated Title: Cancer

Publisher: Wiley

ISSN (Print): 0008-543X

ISSN (Electronic): 1097-0142

Publication date Created: December 17 2018

Publication date (Electronic): December 17 2018

Affiliations

[1 ]Department of Clinical Sciences Lund University Lund Sweden

[2 ]Pediatric Oncology and Hematology Skane University Hospital Lund Sweden

[3 ]Institute for Cancer Outcomes and Survivorship University of Alabama at Birmingham Birmingham Alabama

[4 ]Department of Population Sciences City of Hope Duarte California

[5 ]Pediatric and Familial Cancer Research Group, Cancer Research UK Royal Manchester Children's Hospital Manchester United Kingdom

[6 ]Emma Children's Hospital, Academic Medical Center Amsterdam The Netherlands

[7 ]Department of Pediatric Hematology/Oncology Dana‐Farber Cancer Institute Boston Massachusetts

[8 ]Division of Hematology, Oncology, and Stem Cell Transplantation, Department of Pediatrics Northwestern University Feinberg School of Medicine Chicago Illinois

[9 ]Center for Childhood Cancer Research, Department of Pediatrics University of Pennsylvania School of Medicine Philadelphia Pennsylvania

[10 ]Department of Pediatrics The Ohio State University College of Medicine Columbus Ohio

[11 ]Division of Hematology/Oncology Cincinnati Children's Hospital Medical Center Cincinnati Ohio

[12 ]Division of Hematology/Oncology The Hospital for Sick Children Toronto Ontario Canada

[13 ]Department of Pediatrics University of Minnesota Medical School Minneapolis Minnesota

[14 ]Pediatric Oncology Unit IRCCS Foundation National Cancer Institute Milan Italy

[15 ]Children's Center for Cancer and Blood Diseases Children's Hospital Los Angeles Los Angeles California

[16 ]The Children's Hospital of Philadelphia Philadelphia Pennsylvania

[17 ]Department of Epidemiology and Cancer Control St. Jude Children's Research Hospital Memphis Tennessee

[18 ]Department of Pediatrics Gustave Roussy Institute Villejuif France

[19 ]Department of Biostatistics Gustave Roussy Institute Villejuif France

[20 ]Division of Hematology and Oncology, Department of Pediatrics University of Alabama at Birmingham Birmingham Alabama

Article

DOI: 10.1002/cncr.31807

PubMed ID: 30556153

SO-VID: 3316cc03-fb4e-455f-b7da-9464659436a9

License:

http://doi.wiley.com/10.1002/tdm_license_1.1

History

Data availability:

Comments

Comment on this article

scite_

Cited by 11

See all cited by

- Version 1